<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02417792</url>
  </required_header>
  <id_info>
    <org_study_id>2</org_study_id>
    <nct_id>NCT02417792</nct_id>
  </id_info>
  <brief_title>The Association Between Psoriasis and Intestinal Bacterial Population</brief_title>
  <acronym>PIB</acronym>
  <official_title>The Association Between Psoriasis and Intestinal Bacterial Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assuta Hospital Systems</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tel Aviv Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Assuta Hospital Systems</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      At least 20 psoriasis patients will be compared to at least 20 participants without psoriasis
      Bacterial genomic DNA will be extracted from stool samples of participants. The intestinal
      bacterial populations will be compared in order to examine whether there are differences
      between the groups.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Intestinal bacterial population has a significant influence on health and sickness
      conditions. It affects the development and the function of the immune system (Th2, Th1 or
      Th17) by bacterial protein expression and by the composition of the bacterial population.

      Psoriasis is an immune related dermal disease. The trigger for this disease is currently
      unknown but, it is possible that intestinal bacteria are a factor in its development.

      Study design:

      Participants will be divided into 3 groups:

        -  Psoriasis patients treated with topical medications

        -  Psoriasis patients treated with IV or sub-cutaneous medications (e.g biological
           medications)

        -  Healthy participants (control group) Bacterial genomic DNA will be extracted from stool
           samples of participants. The intestinal bacterial populations will be compared in order
           to examine whether there are differences between the groups.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>May 2015</start_date>
  <completion_date type="Anticipated">March 2017</completion_date>
  <primary_completion_date type="Anticipated">January 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>A significant change (P&lt;0.05) in enteric bacterial composition of psoriasis patients (n=20) vs controls (n=20) as assessed by alpha diversity, beta diversity and taxonomic analysis.</measure>
    <time_frame>2 years</time_frame>
    <description>To examine whether fecal bacterial populations of psoriasis patients (not treated by enteral medications) are different compared to healthy participants</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Psoriasis</condition>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <description>group of healthy participants</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Topical psoriasis treatment</arm_group_label>
    <description>Group of patients who are treated with topical medications for psoriasis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Systemic psoriasis treatment</arm_group_label>
    <description>Group of patients who are treated with systematic medications for psoriasis</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      stool
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Both psoriasis patients and healthy participants (as a control group) will be recruited for
        the study.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Dermal psoriasis patients diagnosed by a dermatologist.

        Exclusion Criteria:

          -  Treatment with antibiotics or probiotics within the prior 3 months.

          -  incapable of signing an inform concent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jonathan Shapiro, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maccabi Healthcare Services, Israel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jonathan Shapiro, Dr.</last_name>
    <phone>972-50-5759516</phone>
    <email>jonmidi@gmail.com</email>
  </overall_contact>
  <reference>
    <citation>Shaw SY, Blanchard JF, Bernstein CN. Association between early childhood otitis media and pediatric inflammatory bowel disease: an exploratory population-based analysis. J Pediatr. 2013 Mar;162(3):510-4. doi: 10.1016/j.jpeds.2012.08.037. Epub 2012 Oct 17.</citation>
    <PMID>23084703</PMID>
  </reference>
  <reference>
    <citation>Shaw SY, Blanchard JF, Bernstein CN. Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease. Am J Gastroenterol. 2010 Dec;105(12):2687-92. doi: 10.1038/ajg.2010.398. Epub 2010 Oct 12.</citation>
    <PMID>20940708</PMID>
  </reference>
  <reference>
    <citation>Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Pe√±a AG, Goodrich JK, Gordon JI, Huttley GA, Kelley ST, Knights D, Koenig JE, Ley RE, Lozupone CA, McDonald D, Muegge BD, Pirrung M, Reeder J, Sevinsky JR, Turnbaugh PJ, Walters WA, Widmann J, Yatsunenko T, Zaneveld J, Knight R. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010 May;7(5):335-6. doi: 10.1038/nmeth.f.303. Epub 2010 Apr 11.</citation>
    <PMID>20383131</PMID>
  </reference>
  <reference>
    <citation>Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics. 2010 Oct 1;26(19):2460-1. doi: 10.1093/bioinformatics/btq461. Epub 2010 Aug 12.</citation>
    <PMID>20709691</PMID>
  </reference>
  <reference>
    <citation>Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol. 1985 Sep;13(3):450-6.</citation>
    <PMID>4056119</PMID>
  </reference>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 13, 2015</study_first_submitted>
  <study_first_submitted_qc>April 15, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 16, 2015</study_first_posted>
  <last_update_submitted>April 16, 2015</last_update_submitted>
  <last_update_submitted_qc>April 16, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 17, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>psoriasis</keyword>
  <keyword>microbiota</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Psoriasis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

